Goldman Sachs Group Inc Blueprint Medicines Corp Put Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

May 14, 2024
BUY
$42.2 - $66.37 $21,100 - $33,185
500 Added 4.85%
10,800 $682,000
Q2 2023

Aug 14, 2023
BUY
$42.2 - $66.37 $21,100 - $33,185
500 Added 4.85%
10,800 $682,000
Q1 2023

May 14, 2024
SELL
$37.97 - $50.0 $18,985 - $25,000
-500 Reduced 4.63%
10,300 $463,000
Q1 2023

May 11, 2023
BUY
$37.97 - $50.0 $391,091 - $515,000
10,300 New
10,300 $463,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email